Use of ctDNA for Real-Time Monitoring of Clinical Benefit in Cancer Patient

Time: 1:30 pm
day: Day One

Details:

  • Looking at ctDNA as a biomarker for evaluating patient responses
  • Navigating different avenues to reach the same results
  • Discussing the views on what actually matters

Speakers: